Dr. Elijah Nazarzadeh is the founder and Chief Scientific Officer of Nebu~Flow. He holds a Master of Engineering in Fluid mechanics & Thermodynamics, and a Ph.D. in Fluid Mechanics from King’s College London, in the UK (2013). Elijah’s research in […]

Alan has focused his career on the development of drugs for respiratory delivery with nearly 15 years’ experience in development of inhalation products in industrial and academic settings. Prior to his role as Director of Technology & Innovation for Inhalation […]

James Lovgren is the CEO and Co-founder of Aspiro Therapeutics, a preclinical-stage company developing a novel inhaled peptide therapeutic for obstructive lung diseases. The company’s lead program focuses on a CC16-derived peptidomimetic designed to address underlying disease biology in asthma […]

Irena King, PhD, is a medical engineer, neuroscientist, and Founder & CEO of Surgicure Technologies, a MedTech company advancing next-generation airway safety solutions for critical care and military medicine. She trained in the MIT–Harvard Health Sciences and Technology (HST) program, […]

Mahendra G Shah, PH.D. has over 50 years of experience in Pharma/Biopharma industry as a scientist, entrepreneur, investor, board member and mentor. Dr. Shah is the founder of Semnur pharmaceuticals, Nextwave Pharmaceuticals and Prism Pharmaceuticals. He was also on the […]

Heather Berger, Ph.D., is a Venture Partner at Forge Life Science Partners, a boutique life science investment fund, focused on novel therapeutics including respiratory products. She is currently a Board Observer for Kinaset Therapeutics, focused on novel inhaled therapeutics for […]

David Lechuga-Ballesteros is Head of Innovation in Global Inhalation Product Development at AstraZeneca, where he leads the design and translation of next-generation inhaled medicines. Trained as a pharmaceutical scientist with deep expertise in spray drying, particle engineering, and solid-state formulation, […]

Eva Littringer is Co-founder and inventor at RevIVe Medtech GmbH and Oncofuse GmbH, and serves as Associate Director of Science & Technology at Novartis, where she operates at the intersection of pharmaceutical innovation, medical device development, and entrepreneurial execution to […]

Puja Myles is Director of the Medicines and Healthcare products Regulatory Agency’s (MHRA) specialist real world data research service, the Clinical Practice Research Datalink (CPRD). She is a public health specialist and prior to joining CPRD, was a public health […]

Dr. García Arieta is Head of Pharmacokinetics and Generic Medicines of the Spanish Agency for Medicines and Health Care Products and Consultant for WHO Prequalification of Medicines Programme. He was also member of the Methodology Working Party and the Pharmacokinetics […]